Natco Pharma Ltd. (NATP)

840.00 -2.00 (-0.24%)
Close INR Disclaimer

NATP Financial Summary

For the six months ended 30 September 2021, NatcoPharma Ltd. revenues decreased 42% to RS7.88B. Net incomedecreased 57% to RS1.4B. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Net income also reflectsDepreciation and amortisation expense increase of 21% toRS685M (expense). Dividend per share decreased from RS4.25to RS2.50.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
NATP
Gross margin TTM 79.02%
Operating margin TTM 14.27%
Net Profit margin TTM 17.4%
Return on Investment TTM 5.97%
Total Revenue
Net Income
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Total Revenue 3,772 4,103 3,313 3,552
Gross Profit 2,847 3,312 2,768 2,721
Operating Income 358 760 458 527
Net Income 651 750 530 627
Clear All
0Selected
Please try another search
NATP
Quick Ratio MRQ 2.45
Current Ratio MRQ 3.84
LT Debt to Equity MRQ 0.22%
Total Debt to Equity MRQ 8.78%
Total Assets
Total Liabilities
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Total Assets 50,517 47,919
Total Liabilities 8,230 6,703
Total Equity 42,287 41,216
Clear All
0Selected
Please try another search
NATP
Cash Flow/Share TTM 21.11
Revenue/Share TTM 80.77
Operating Cash Flow -7.58%
Cash
Net Change in Cash
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Cash From Operating Activities -499 2,988
Cash From Investing Activities 517 -1,033
Cash From Financing Activities 486 -1,857
Net Change in Cash 440 60
Clear All
0Selected
Please try another search

* In Millions of INR (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles